Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dietary naringenin supplementation attenuates experimental autoimmune encephalomyelitis by modulating autoimmune inflammatory responses in mice
Junpeng Wang, Ying Qi, Xinli Niu, et al.
The Journal of Nutritional Biochemistry (2017) Vol. 54, pp. 130-139
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis
Łucja Justyna Walczak-Nowicka, Mariola Herbet
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9290-9290
Open Access | Times Cited: 157
Naringenin: A flavanone with anti-inflammatory and anti-infective properties
Cai Ji, Hongli Wen, He Zhou, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114990-114990
Open Access | Times Cited: 74
Polyphenols: immunonutrients tipping the balance of immunometabolism in chronic diseases
Carolina Ferreira, Pedro Vieira, Susana Machado, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 23
The Role of Diet in Multiple Sclerosis: Mechanistic Connections and Current Evidence
Ilana Katz Sand
Current Nutrition Reports (2018) Vol. 7, Iss. 3, pp. 150-160
Open Access | Times Cited: 142
The role of flavonoids in autoimmune diseases: Therapeutic updates
Kannan R. R. Rengasamy, Haroon Khan, Shanmugaraj Gowrishankar, et al.
Pharmacology & Therapeutics (2018) Vol. 194, pp. 107-131
Closed Access | Times Cited: 142
On the Neuroprotective Effects of Naringenin: Pharmacological Targets, Signaling Pathways, Molecular Mechanisms, and Clinical Perspective
Zeinab Nouri, Sajad Fakhri, Fardous F. El‐Senduny, et al.
Biomolecules (2019) Vol. 9, Iss. 11, pp. 690-690
Open Access | Times Cited: 113
Recent advances in extracting phenolic compounds from food and their use in disease prevention and as cosmetics
Ricardo Dias, Hélder Oliveira, Iva Fernandes, et al.
Critical Reviews in Food Science and Nutrition (2020) Vol. 61, Iss. 7, pp. 1130-1151
Closed Access | Times Cited: 110
Targeting apoptosis and autophagy following spinal cord injury: Therapeutic approaches to polyphenols and candidate phytochemicals
Fatemeh Abbaszadeh, Sajad Fakhri, Haroon Khan
Pharmacological Research (2020) Vol. 160, pp. 105069-105069
Closed Access | Times Cited: 108
Targeting Keap1/Nrf2/ARE signaling pathway in multiple sclerosis
Danica Michaličková, Tomáš Hrnčíř, Nikolina Kutinová Canová, et al.
European Journal of Pharmacology (2020) Vol. 873, pp. 172973-172973
Closed Access | Times Cited: 87
Naringenin Produces Neuroprotection Against LPS-Induced Dopamine Neurotoxicity via the Inhibition of Microglial NLRP3 Inflammasome Activation
Ce Chen, Yi-Zheng Wei, Xuemei He, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 70
Naringenin: its chemistry and roles in neuroprotection
Ayomide Victor Atoki, Patrick Maduabuchi Aja, Tijjani Salihu Shinkafi, et al.
Nutritional Neuroscience (2023) Vol. 27, Iss. 6, pp. 637-666
Closed Access | Times Cited: 17
Flavonoids, the compounds with anti-inflammatory and immunomodulatory properties, as promising tools in multiple sclerosis (MS) therapy: A systematic review of preclinical evidence
Payam Bayat, Maral Farshchi, Mozhdeh Yousefian, et al.
International Immunopharmacology (2021) Vol. 95, pp. 107562-107562
Closed Access | Times Cited: 36
Immunomodulatory potential of flavonoids for the treatment of autoimmune diseases and tumour
Limin Han, Qiang Fu, Chuan Deng, et al.
Scandinavian Journal of Immunology (2021) Vol. 95, Iss. 1
Open Access | Times Cited: 34
Naringenin suppresses neutrophil infiltration into adipose tissue in high-fat diet-induced obese mice
Rika Tsuhako, Hiroki Yoshida, Chihiro Sugita, et al.
Journal of Natural Medicines (2019) Vol. 74, Iss. 1, pp. 229-237
Closed Access | Times Cited: 40
Polyphenols Targeting Oxidative Stress in Spinal Cord Injury: Current Status and Future Vision
Fahadul Islam, Sristy Bepary, Mohamed H. Nafady, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-21
Open Access | Times Cited: 21
The druggability of bitter taste receptors for the treatment of neurodegenerative disorders
Ana Catarina Duarte, Ana R. Costa, Isabel Gonçalves, et al.
Biochemical Pharmacology (2022) Vol. 197, pp. 114915-114915
Open Access | Times Cited: 20
Naringenin as a natural immunomodulator against T cell-mediated autoimmune diseases: literature review and network-based pharmacology study
Zejin Liu, Xinli Niu, Junpeng Wang
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 32, pp. 11026-11043
Closed Access | Times Cited: 20
The effect of immunomodulatory properties of naringenin on the inhibition of inflammation and oxidative stress in autoimmune disease models: a systematic review and meta-analysis of preclinical evidence
Mina Alimohammadi, Rebar N. Mohammad, Ali Rahimi, et al.
Inflammation Research (2022) Vol. 71, Iss. 10-11, pp. 1127-1142
Closed Access | Times Cited: 20
Polyphenols and inflammatory bowel disease: Natural products with therapeutic effects?
Mostafa Vaghari‐Tabari, Forough Alemi, Maryam Zokaei, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 64, Iss. 13, pp. 4155-4178
Closed Access | Times Cited: 20
Potential Beneficial Effects of Naringin and Naringenin on Long COVID—A Review of the Literature
Siqi Liu, Mengli Zhong, Hao Wu, et al.
Microorganisms (2024) Vol. 12, Iss. 2, pp. 332-332
Open Access | Times Cited: 4
Naringenin Inhibit the Hydrogen Peroxide-Induced SH-SY5Y Cells Injury Through Nrf2/HO-1 Pathway
Yuzi Jin, Hua Wang
Neurotoxicity Research (2019) Vol. 36, Iss. 4, pp. 796-805
Closed Access | Times Cited: 31
Naringenin attenuates experimental autoimmune encephalomyelitis by protecting the intact of blood-brain barrier and controlling inflammatory cell migration
Xinli Niu, Hongzhen Sang, Junpeng Wang
The Journal of Nutritional Biochemistry (2020) Vol. 89, pp. 108560-108560
Closed Access | Times Cited: 31
Microglial Phagocytosis—Rational but Challenging Therapeutic Target in Multiple Sclerosis
Maria V. Pinto, Adelaide Fernandes
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 5960-5960
Open Access | Times Cited: 30
In Vitro Bioaccessibility of Bioactive Compounds from Citrus Pomaces and Orange Pomace Biscuits
Adriana Maite Fernández‐Fernández, Eduardo Dellacassa, Tiziana Nardin, et al.
Molecules (2021) Vol. 26, Iss. 12, pp. 3480-3480
Open Access | Times Cited: 24
Natural compounds as potential therapeutic candidates for multiple sclerosis: Emerging preclinical evidence
Jinfeng Yuan, Yanlin Tao, Mengxue Wang, et al.
Phytomedicine (2023) Vol. 123, pp. 155248-155248
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top